| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| CLOFIBRATE DISCONTINUED (has an active metabolite)
| CLOFIBRATE | CARDIOVASCULAR | ORAL | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Peroxisome proliferator-activated receptor alpha UNIPROT Q07869 PPARA more at DrugCentral | EMA | ||||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M CLOFIBRATE (is an active metabolite)
| CLOFIBRATE | CARDIOVASCULAR | - | Cmax 932.8 MICROMOLAR PPB 96 PERCENT HT 20 HOUR | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR PDB 7BPY (X-RAY STRUCTURE OF HUMAN PPARALPHA LIGAND BINDING DOMAIN-CLOFIBRIC ACID-SRC1 COACTIVATOR PEPTIDE CO-CRYSTALS OBTAINED BY DELIPIDATION AND CO-CRYSTALLIZATION) LIGAND CODE = E0O (link to the list of PDB complexes) Download experimental 3D coordinates of E0O with added hydrogens | Peroxisome proliferator-activated receptor alpha UNIPROT Q07869 PPARA more at DrugCentral | EMA | |||
